BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8502117)

  • 1. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
    Young AA; Rink TJ; Wang MW
    Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo.
    Wang MW; Young AA; Rink TJ; Cooper GJ
    FEBS Lett; 1991 Oct; 291(2):195-8. PubMed ID: 1936264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of acute hyperglycemia, hyperlactemia and hypocalcemia in fed and fasted BALB/c mice by intravenous amylin injection.
    Wang MW; Carlo P; Fineman M; Rink TJ; Young AA
    Endocr Res; 1992; 18(4):321-32. PubMed ID: 1473524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats.
    Wang MW; Carlo P; Rink TJ; Young AA
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1288-93. PubMed ID: 1764079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
    Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
    Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats.
    Vine W; Beaumont K; Gedulin B; Pittner R; Moore CX; Rink TJ; Young AA
    Eur J Pharmacol; 1996 Oct; 314(1-2):115-21. PubMed ID: 8957226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
    Haynes JM; Hodgson WC; Cooper ME
    Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on plasma glucose and lactate.
    Young A
    Adv Pharmacol; 2005; 52():193-208. PubMed ID: 16492547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations.
    Giuliani S; Wimalawansa SJ; Maggi CA
    Br J Pharmacol; 1992 Oct; 107(2):510-4. PubMed ID: 1330181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity.
    Young AA; Wang MW; Gedulin B; Rink TJ; Pittner R; Beaumont K
    Metabolism; 1995 Dec; 44(12):1581-9. PubMed ID: 8786728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats.
    Lutz TA; Rossi R; Althaus J; Del Prete E; Scharrer E
    Peptides; 1998; 19(9):1533-40. PubMed ID: 9864060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
    Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
    Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.
    Beaumont K; Pittner RA; Moore CX; Wolfe-Lopez D; Prickett KS; Young AA; Rink TJ
    Br J Pharmacol; 1995 Jul; 115(5):713-5. PubMed ID: 8548167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones.
    Riediger T; Schmid HA; Young AA; Simon E
    Brain Res; 1999 Aug; 837(1-2):161-8. PubMed ID: 10433998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.
    Beaumont K; Moore CX; Pittner RA; Prickett KS; Gaeta LS; Rink TJ; Young AA
    Can J Physiol Pharmacol; 1995 Jul; 73(7):1025-9. PubMed ID: 8846395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.
    Pittner RA; Wolfe-Lopez D; Young AA; Beaumont K
    Br J Pharmacol; 1996 Mar; 117(5):847-52. PubMed ID: 8851500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts.
    Alam AS; Moonga BS; Bevis PJ; Huang CL; Zaidi M
    Exp Physiol; 1993 Mar; 78(2):183-96. PubMed ID: 8385961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide.
    Svensson AM; Sandler S; Jansson L
    Diabetes; 1994 Mar; 43(3):454-8. PubMed ID: 8314019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin-induced relaxation of the perfused mesenteric arterial bed: meditation by calcitonin gene-related peptide receptors.
    Westfall TC; Curfman-Falvey M
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):932-6. PubMed ID: 8606530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin, calcitonin gene-related peptide, and adrenomedullin: effects on thiazide receptor and calcium.
    Blakely P; Vaughn DA; Fanestil DD
    Am J Physiol; 1997 Mar; 272(3 Pt 2):F410-5. PubMed ID: 9087686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.